医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

湖州地区消化系统疾病幽门螺杆菌耐药情况及根除疗效分析

Analysis of antibiotic resistance and eradicatation effects of Helicobacter pylori in digestive diseases in Huzhou district

摘要目的 了解浙江省湖州地区H.pylori常用抗菌药物的耐药变迁,总结相关消化系统疾病的根除疗效.方法 收集2009、2013、2014、2015年8 1 39例胃镜检查患者的胃黏膜标本,进行H.pylori分离培养,分析左氧氟沙星、克拉霉素、甲硝唑、阿莫西林、四环素和呋喃唑酮的耐药现状,分析功能性消化不良、慢性胃炎、急性胃炎、十二指肠炎、胃溃疡、十二指肠溃疡、胃肠功能紊乱、胃癌、残胃炎、反流性食管炎、胃淋巴瘤11种疾病的H.pylori感染情况和H.pylori的耐药情况,以及功能性消化不良、慢性胃炎、十二指肠炎、胃溃疡、十二指肠溃疡、反流性食管炎6种消化系统疾病的H.pylori根除方案和根除率.以Fisher确切概率法比较各组率的差异.结果 共3 263例获得H.pylori临床分离株,H.pylori感染率为40.09%(3 263/8 139).11种消化系统疾病的H.pylori感染率为0~57.89%,其中十二指肠溃疡、胃溃疡、十二指肠炎、慢性胃炎、功能性消化不良感染率较高,分别为57.89%(726/1 254)、49.83%(301/604)、42.91%(118/275)、37.45%(1 518/4 053)、36.78%(146/397).需要根除或计划根除H.pylori的6个病种的单一抗菌药物耐药分析显示,H.pylori对左氧氟沙星和克拉霉素的耐药率分别达到23.09%(663/2 871)和17.87%(513/2 871),左氧氟沙星的耐药率由2009年的5.03%(8/159)急剧升高至2015年的28.24%(586/2 075),克拉霉素的耐药率由2009年的12.58%(20/159)较快升高至2015年的21.78% (452/2 075);H.pylori对甲硝唑的耐药率一直接近100.00%;对阿莫西林、四环素和呋喃唑酮的耐药率均为0.需要根除或计划根除H.pylori的6个病种的总体双重耐药率分析发现,左氧氟沙星和克拉霉素同时耐药率为7.73%(222/2 871).不同病种的H.pylori对左氧氟沙星和克拉霉素双重耐药率波动在4.82%~10.96%.6种消化系统疾病中的1 479例给予四联方案根治治疗,根治治疗后随访1 363例患者,根除率为85.99%(1 172/1 363).结论 对湖州地区常见的需要根除或计划根除H.pylori的6种消化系统疾病而言,应该首选阿莫西林、四环素、呋喃唑酮的两两组合进行治疗.如果对青霉素过敏或呋喃唑酮、四环素无法获得的情况下,再考虑选用左氧氟沙星和克拉霉素.监测并根据本地区的H.pylori药物敏感试验结果选择根除治疗方案能够取得较好的根除率.

更多

abstractsObjective To investigate the antibiotic resistance trend of commonly used antibiotics of Helicobacter pylori (H.pylori) in Huzhou district,and to summarize the efficacy of eradication in related digestive diseases.Methods In year 2009,2013,2014 and 2015,8 139 gastric mucosa samples of patients undergoing gastroendoscopy examination were collected and H.pylori strains were isolated and cultured.The situation of resistance to levofloxacin,clarithromycin,metronidazole,amoxicillin,tetracycline and furazolidone was analyzed.The infection and antibiotics resistance of H.pylori were analyzed in 11 digestive diseases including functional dyspepsia,chronic gastritis,acute gastritis,duodenitis,gastric ulcer,duodenal ulcer,gastrointestinal dysfunction,gastric cancer,residual gastritis,reflux esophagitis and gastric lymphoma.The eradication schemes and eradication rate of H.pylori was reviewed in six digestive diseases including functional dyspepsia,chronic gastritis,duodenitis,gastric ulcer,duodenal ulcer and reflux esophagitis.Fisher's exact test was performed to compare the differences among the groups.Results A total of 3 263 H.pylori strains were obtained and the infection rate of H.pylori was 40.09% (3 263/8 139).The H.pylori infection rates of 11 digestive diseases were from 0 to 57.89%,and which was high in duodenal ulcer,gastric ulcer,duodenitis,chronic gastritis and functional dyspepsia (57.89%,726/1 254;49.83%,301/604;42.91%,118/275;37.45%,1 518/4 053 and 36.78%,146/397;respectively).The results of single antibiotic resistance analysis in six digestive diseases needed or planed for H.pylori eradication indicated that resistance rate of H.pylori to levofloxacin and clarithromycin reached 23.09% (663/2 871) and 17.87% (513/2 871),respectively.The resistance rate tolevofloxacin dramatically increased from 5.03% (8/159) in 2009 to 28.24% (586/2 075) in 2015;the resistance rate to clarithromycin increased from 12.58% (20/159) in 2009 to 21.78% (452/2 075) in 2015;meanwhile,the resistance rate of H.pylori to metronidazole was nearly 100.00%.However,the resistance rates to amoxicillin,tetracycline and tetracycline were all zero.The results of double antibiotic resistance analysis in six digestive diseases needed or planed for H.pylori eradication indicated that the rate of both levofloxacin and clarithromycin resistance was 7.73 % (222/2 871).The double antibiotic resistance rate of levofloxacin and clarithromycin in different diseases fluctuated between 4.82 % and 10.96 %.Totally 1 479patients of six digestive diseases were treated with quadruple therapy,and 1 363 patients were followed up after eradication therapy,with the eradication rate of 85.99% (1 172/1 363).Conclusions In Huzhou district,for six common digestive diseases needed or planed for H.pylori eradication,any combination of two drugs in all three drugs including amoxicillin,tetracycline and furazolidone is the first choice for treatment.Only when patients are allergic to penicillin or furazolidone and tetracycline can not be obtained,will levofloxacin and clarithromycin be chosen.A high eradication rate can be achieved by choosing eradication schemes according to the results of H.pylori drug sensitivity test in local region.

More
广告
栏目名称
DOI 10.3760/cma.j.issn.0254-1432.2017.12.003
发布时间 2018-01-26(万方平台首次上网日期,不代表论文的发表时间)
基金项目
Zhejiang Medical and Health Fund Project ((2014ZHA010)浙江省卫生适宜技术成果转化计划(2014ZHA010))
  • 浏览536
  • 下载161
中华消化杂志

中华消化杂志

2017年37卷12期

801-805页

ISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷